Your browser doesn't support javascript.
loading
SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin.
Hurkmans, Evelien G E; Koenderink, Jan B; van den Heuvel, Jeroen J M W; Versleijen-Jonkers, Yvonne M H; Hillebrandt-Roeffen, Melissa H S; Groothuismink, Johanne M; Vos, Hanneke I; van der Graaf, Winette T A; Flucke, Uta; Muradjan, Grigor; Schreuder, Hendrik W B; Hagleitner, Melanie M; Brunner, Han G; Gelderblom, Hans; Cleton-Jansen, Anne-Marie; Guchelaar, Henk-Jan; de Bont, Eveline S J M; Touw, Daan J; Nijhoff, G Jan; Kremer, Leontien C M; Caron, Huib; Windsor, Rachael; Patiño-García, Ana; González-Neira, Anna; Saletta, Federica; McCowage, Geoff; Nagabushan, Sumanth; Catchpoole, Daniel; Te Loo, D Maroeska W M; Coenen, Marieke J H.
Afiliación
  • Hurkmans EGE; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.
  • Koenderink JB; Department of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, Netherlands.
  • van den Heuvel JJMW; Department of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, Netherlands.
  • Versleijen-Jonkers YMH; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands.
  • Hillebrandt-Roeffen MHS; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands.
  • Groothuismink JM; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.
  • Vos HI; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.
  • van der Graaf WTA; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands.
  • Flucke U; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Muradjan G; Department of Pathology, Radboud University Medical Center, Nijmegen, Netherlands.
  • Schreuder HWB; Department of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, Netherlands.
  • Hagleitner MM; Department of Orthopedics, Radboud University Medical Center, Nijmegen, Netherlands.
  • Brunner HG; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Gelderblom H; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.
  • Cleton-Jansen AM; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands.
  • Guchelaar HJ; Department of Pathology, Leiden University Medical Center, Leiden, Netherlands.
  • de Bont ESJM; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, Netherlands.
  • Touw DJ; Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, Groningen, Netherlands.
  • Nijhoff GJ; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, Netherlands.
  • Kremer LCM; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, Netherlands.
  • Caron H; Department of Pediatrics, Amsterdam University Medical Centers, Emma Children's Hospital, Amsterdam, Netherlands.
  • Windsor R; Department of Pediatrics, Amsterdam University Medical Centers, Emma Children's Hospital, Amsterdam, Netherlands.
  • Patiño-García A; Pediatric & Adolescent Division, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • González-Neira A; Department of Pediatrics, Clínica Universidad de Navarra, Solid Tumor Program, CIMA, Pamplona, Spain.
  • Saletta F; Human Genotyping Unit-CeGen, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • McCowage G; Children's Cancer Research Unit, The Children's Hospital at Westmead, Sydney, NSW, Australia.
  • Nagabushan S; Cancer Centre for Children, The Children's Hospital at Westmead, Sydney, NSW, Australia.
  • Catchpoole D; Cancer Centre for Children, The Children's Hospital at Westmead, Sydney, NSW, Australia.
  • Te Loo DMWM; Discipline of Child and Adolescent Health, University of Sydney, Sydney, NSW, Australia.
  • Coenen MJH; Children's Cancer Research Unit, The Children's Hospital at Westmead, Sydney, NSW, Australia.
Front Pharmacol ; 13: 1042989, 2022.
Article en En | MEDLINE | ID: mdl-36438828
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Suiza